These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18239285)

  • 41. Influence of technological procedures on viability, probiotic and anti-mycotoxin properties of
    Poloni VL; Bainotti MB; Vergara LD; Escobar F; Montenegro M; Cavaglieri L
    Curr Res Food Sci; 2021; 4():132-140. PubMed ID: 33778773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut.
    Samonis G; Falagas ME; Lionakis S; Ntaoukakis M; Kofteridis DP; Ntalas I; Maraki S
    Med Mycol; 2011 May; 49(4):395-9. PubMed ID: 21077734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved probiotic viability in stress environments with post-culture of alginate-chitosan microencapsulated low density cells.
    Song H; Yu W; Liu X; Ma X
    Carbohydr Polym; 2014 Aug; 108():10-6. PubMed ID: 24751241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
    Sheshala R; Khan N; Darwis Y
    Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the Probiotic Saccharomyces boulardii on Cholesterol and Lipoprotein Particles in Hypercholesterolemic Adults: A Single-Arm, Open-Label Pilot Study.
    Ryan JJ; Hanes DA; Schafer MB; Mikolai J; Zwickey H
    J Altern Complement Med; 2015 May; 21(5):288-93. PubMed ID: 25893960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Datta S; Timson DJ; Annapure US
    J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
    Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
    Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Saccharomyces boulardii does not prevent relapse of Crohn's disease.
    Bourreille A; Cadiot G; Le Dreau G; Laharie D; Beaugerie L; Dupas JL; Marteau P; Rampal P; Moyse D; Saleh A; Le Guern ME; Galmiche JP;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):982-7. PubMed ID: 23466709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae.
    Edwards-Ingram L; Gitsham P; Burton N; Warhurst G; Clarke I; Hoyle D; Oliver SG; Stateva L
    Appl Environ Microbiol; 2007 Apr; 73(8):2458-67. PubMed ID: 17293506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Process Parameters, Protectants and Carrier Materials on the Survival of Yeast Cells during Fluidized Bed Granulation for Tableting.
    Vorländer K; Bahlmann L; Kwade A; Finke JH; Kampen I
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Foam-Mat Freeze-Drying of Bifidobacterium longum RO175: Viability and Refrigerated Storage Stability.
    Izquierdo-López D; Goulet J; Ratti C
    J Food Sci; 2017 Jan; 82(1):90-96. PubMed ID: 27886651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres.
    Devrim B; Bozkir A; Canefe K
    Acta Pol Pharm; 2011; 68(4):593-9. PubMed ID: 21796942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
    Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
    Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physico-chemical comparison of famotidine tablets prepared via dry granulation and direct compression techniques.
    Baseer A; Hassan F; Hassan SF; Jabeen S; Israr F; Murtaza G; Haque N
    Pak J Pharm Sci; 2013 May; 26(3):439-43. PubMed ID: 23625414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Joint protection strategies for Saccharomyces boulardii: exogenous encapsulation and endogenous biofilm structure.
    Meng KL; Lv XC; Che HY; Li Y; Chen XL; Hu MX; Yan M
    Appl Microbiol Biotechnol; 2021 Nov; 105(21-22):8469-8479. PubMed ID: 34647135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
    Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
    Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-Saccharomyces yeasts protect against epithelial cell barrier disruption induced by Salmonella enterica subsp. enterica serovar Typhimurium.
    Smith IM; Baker A; Arneborg N; Jespersen L
    Lett Appl Microbiol; 2015 Nov; 61(5):491-7. PubMed ID: 26280244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.